Devron R. Shah
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 4
- HER2/EGFR in Cancer Research 3
-
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Rashmi R. Shah (7 shared papers)Joel Morganroth (3 shared papers)Shamik Dholakia (1 shared paper)Samantha Roberts (1 shared paper)Dominic L. Sykes (1 shared paper)Simon P. Hart (1 shared paper)
- Journals
- Drug Safety (5 papers)British Journal of Clinical Pharmacology (2 papers)Drugs - Real World Outcomes (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Devron R. Shah
7 papers receiving 605 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 74
- Oncology 195
- Hematology 82
- Pulmonary and Respiratory Medicine 154
- Hepatology 31
Countries citing papers authored by Devron R. Shah
This map shows the geographic impact of Devron R. Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devron R. Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devron R. Shah more than expected).
Fields of papers citing papers by Devron R. Shah
This network shows the impact of papers produced by Devron R. Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devron R. Shah. The network helps show where Devron R. Shah may publish in the future.
Co-authors
The 6 scholars most cited alongside Devron R. Shah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 212 | |
| 2 | 2013 | 125 | |
| 3 | 2013 | 117 | |
| 4 | 2019 | 70 | |
| 5 | 2012 | 45 | |
| 6 | 2014 | 42 | |
| 7 | 2013 | 27 | |
| 8 | 2025 | 0 |
About Devron R. Shah
Devron R. Shah is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Pharmacology and Molecular Biology, having authored 8 papers that have together received 638 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (3 papers), HER2/EGFR in Cancer Research (3 papers), Pharmacogenetics and Drug Metabolism (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Wound Healing and Treatments (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Pharmacology (74 citations), Oncology (195 citations), Hematology (82 citations), Pulmonary and Respiratory Medicine (154 citations) and Hepatology (31 citations). Devron R. Shah has collaborated with scholars based in United Kingdom. Frequent co-authors include Rashmi R. Shah, Joel Morganroth, Shamik Dholakia, Samantha Roberts, Dominic L. Sykes and Simon P. Hart. Their work appears in journals such as Drug Safety, British Journal of Clinical Pharmacology and Drugs - Real World Outcomes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.